Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
which viruses hijack chromatin. Due to the major advancement in sequencing technologies and the expansion of the field of epigenetics, exploiting viruses to investigate chromatin biology has enormous
-
, including gene expression, epigenetic, endocrine, and behavioral datasets. Responsibilities include supporting data processing workflows, assisting with molecular assays, and collaborating closely with other
-
understand the role of chromatin modifiers and epigenetic factors and find novel therapeutic opportunities in myeloid malignancies, including myelodysplastic syndromes and acute myeloid leukemia. JOB TITLE
-
Aging and Alzheimer's Disease A. La Spada: Mechanisms of Neurodegenerative Disease / Neurotherapeutics J. Lipkova: Artificial Intelligence in Medicine. https://octopath.org/ M. Rose: Neuronal Diversity
-
epigenetic regulators, both in physiological and pathological conditions. In the context of a project funded by the French Research Agency (ANR), you will characterise a potential new class of transcriptional
-
to be determined pending application date and program needs. Group or Departmental Website: http://flentje.stanford.edu (link is external) How to Submit Application Materials: Submit your application via
-
, epigenetics, metabolism, tumor heterogeneity, tumor microenvironment, and the effects of therapy on normal brain tissue. Candidates focused on pediatric or adult brain tumor research, and with a strong interest
-
-related fields: genetics, epigenetics, inflammation, metabolic pathology, autoinflammatory pathology, autoimmunity, arthritis, of which at least 1 publication as first author - Previous experience
-
scientific diver credentials such as AAUS certification. Additional assets include experience with other omics approaches or epigenetics, advanced coding skills in R or Python, and prior supervisory experience
-
of phenotypic and preclinical data from a range of high-throuhput molecular profiling. Of particular interest is the role of the epigenetically modulated changes in gene regulatory programs in therapy resistance